Drug Shortage Report for CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Report ID | 208850 |
Drug Identification Number | 02230302 |
Brand name | CODEINE CONTIN 50MG CONTROLLED RELEASE TAB |
Common or Proper name | Codeine Controlled Release Tablets |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | CODEINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-11-01 |
Actual start date | 2023-11-01 |
Estimated end date | 2024-01-05 |
Actual end date | 2024-01-04 |
Shortage status | Resolved |
Updated date | 2024-01-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-05 | English | Compare |
v9 | 2024-01-04 | French | Compare |
v8 | 2024-01-04 | English | Compare |
v7 | 2023-12-08 | French | Compare |
v6 | 2023-12-08 | English | Compare |
v5 | 2023-11-22 | French | Compare |
v4 | 2023-11-22 | English | Compare |
v3 | 2023-11-02 | English | Compare |
v2 | 2023-11-01 | French | Compare |
v1 | 2023-11-01 | English | Compare |
Showing 1 to 10 of 10